Trademark Overview
On Thursday, July 9, 2020, a trademark application was filed for VALAKRAS with the United States Patent and Trademark Office. The USPTO has given the VALAKRAS trademark a serial number of 90044726. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 18, 2021. This trademark is owned by Amgen Inc.. The VALAKRAS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders